Editorial for Special Issue "Cerebrovascular Diseases-From Pathogenesis to Treatment: Opportunities and Challenges". [PDF]
Gasull T, Purroy F, Arboix A.
europepmc +1 more source
Association between SGLT2 inhibitor use and risk of sepsis-induced cardiomyopathy in patients with type 2 diabetes: a propensity-matched cohort study. [PDF]
Wu JY +5 more
europepmc +1 more source
SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study. [PDF]
Cheng WY +7 more
europepmc +1 more source
Real-world observations of GLP-1 receptor agonists and SGLT-2 inhibitors as potential treatments for Alzheimer's disease. [PDF]
Zhang P +11 more
europepmc +1 more source
Linagliptin-Induced Bullous Pemphigoid: A Case Report and Comprehensive Literature Review. [PDF]
Almutairi S +3 more
europepmc +1 more source
Unique Role of Proximal Tubule Dipeptidyl Peptidase 4 on Blood Pressure, Renal Sodium Handling, and Na<sup>+</sup>/H<sup>+</sup> Exchanger Isoform 3 Phosphorylation. [PDF]
Martins FL +4 more
europepmc +1 more source
Ethnic differences in the comparative effectiveness of second-line type 2 diabetes medications in preventing cardiovascular disease. [PDF]
Harley M +7 more
europepmc +1 more source
GLP-1RA and Liver Fibrosis Progression in MASLD and Type 2 Diabetes: Target Trial Emulation Using Propensity Score Matching. [PDF]
Choi J +9 more
europepmc +1 more source
The Effect of Diabetes Medication on the Scores of the GNRI and CONUT Nutritional Indices: Cross-Sectional and Longitudinal Retrospective Studies. [PDF]
Fujita S +9 more
europepmc +1 more source

